|
|
Nervana ~ News ~ Articles
Nervana Introduces Intellectual Property Search Service Tailored for Life Science Organizations
Bellevue, WA, November 15, 2005 – Nervana™, Inc.
Nervana a leading semantic search technology company, today announced Nervana IP Discovery version 1.0, a powerful addition to Nervana’s suite of knowledge discovery solutions that provide life science organizations robust semantic search capabilities that provide higher knowledge interaction and discovery, essential for timely advances in research and development. It’s a significant advancement that increases the data an individual searcher can assimilate, eliminates the need for separate licenses for patent, biotech or pharmacy data sources, and it delivers higher operational and economic efficiency for the customer.
This service comes at a critical time when life science industries are experiencing dramatic increases in money spent on research and development with decreasing return on investments. Nervana IP Discovery helps mitigate the financial risk and increase the long-term protection with efficient upfront discovery of relevant patent knowledge.
To provide this new semantic patent product, Nervana has formed a strategic partnership with PatentCafe, the leading provider of patent data centric enterprise intellectual property asset management (IPAM) software and informational resources. Semantically searching patent and non-patent data simultaneously with Nervana discovery solutions delivers the most relevant results from a collection of the most important life science data sources. The service indexes information and content configured to six life sciences ontologies on a relevant subset of patent data from all the major patent authorities worldwide, providing them easy access to critical knowledge for research and development.
“The Life Sciences industry is facing a critical need for new tools to facilitate efficient drug discovery and to increase R&D productivity,” said Nosa Omoigui, chairman and CEO of Nervana. “Nervana IP Discovery provides knowledge-workers with a more natural and expressive way to conduct patent searches and to discover patents that they otherwise would have missed, thereby providing mission-critical insurance early in the drug discovery and R&D process, and helping to avoid or resolve expensive patent litigation,” said Omoigui.
“The PatentCafe/Nervana partnership creates the world’s largest collection of patent and non-patent data—accessible with a single query, capable of integrating and relevancy-ranking the combined search results,” said Andy Gibbs, CEO of PatentCafe. “As the patent data source for the Nervana system, PatentCafe is helping to establish the new standard for life science research tools that even meta search engines for biotech, pharmaceutical or patent data alone simply can’t provide,” said Gibbs.
About Nervana, Inc.
Nervana Inc. is a leading knowledge discovery technology company. Nervana is the only provider that offers its customers a full-range portfolio of knowledge discovery packages, from intellectual property (patent) to industry specific ontology products for industries with dense multiple data sources and complex structures. The robust functionality, true semantic search, and cross indexing of ontologies can condense knowledge discovery to mere seconds, a task that would take years or decades with other available search tools.
Nervana is a privately held company. For more information, please visit Nervana’s web site at www.nervana.com.
About PatentCafe® (http://iamcafe.com)
PatentCafe is a leading global provider of patent research tools and intellectual property management solutions. Its ICO™ Suite of enterprise solutions transform patent and technical data into actionable business information for legal, technology investment, engineering and business professionals worldwide. ICO™ solutions deliver the next generation data mining and patent informatics for improved patent quality, superior competitive intelligence, licensing revenue optimization, and corporate governance compliance.
Media Contacts:
Amy Cunningham/Write Image (206) 295-6111 amy.cunningham@write-image.com
Kerstin Anderson/Write Image (425) 636-0273 Kerstin.anderson@write-image.com
|
|
|
|